Alphabet’s biolab in funding talks at $40B valuation
The company hopes the new investment will accelerate its push to develop new drugs. Alphabet’s Isomorphic Labs is reportedly in fundraising talks at a $40 billion valuation, the latest sign of strong investor appetite for AI despite growing fears of a bubble. The company — led by Nobel Prize winner and former Google De